Published in J Mol Cell Cardiol on June 01, 1971
Regeneration of the heart. EMBO Mol Med (2011) 1.27
Hyperplasia of myocyte nuclei in long-term cardiac hypertrophy in rats. J Clin Invest (1987) 0.98
Chronic right ventricular pressure overload results in a hyperplastic rather than a hypertrophic myocardial response. J Anat (2008) 0.93
Hypertensive cardiomyopathy. Myocyte nuclei hyperplasia in the mammalian rat heart. J Clin Invest (1990) 0.93
Cardiac stem cell niches. Stem Cell Res (2014) 0.91
Cellular changes in mechanically overloaded heart. Basic Res Cardiol (1977) 0.85
Assessment of the right ventricle by magnetic resonance imaging in chronic obstructive lung disease. Thorax (1990) 0.81
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med (2001) 10.03
Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A (2001) 7.19
Apoptosis in the failing human heart. N Engl J Med (1997) 6.35
Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest (1996) 3.42
Myocyte death in the failing human heart is gender dependent. Circ Res (1999) 3.38
Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res (1991) 3.32
Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation (1994) 3.24
Myocardial cell death in human diabetes. Circ Res (2000) 3.12
Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest (1997) 2.93
Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation (1995) 2.91
Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res (2001) 2.89
Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A (1998) 2.60
Gender differences and aging: effects on the human heart. J Am Coll Cardiol (1995) 2.49
Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res (2001) 2.43
Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci U S A (1996) 2.34
PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation (2000) 2.19
Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci (2001) 2.17
Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J Mol Cell Cardiol (1996) 2.06
Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol (1996) 2.05
Stretch-induced programmed myocyte cell death. J Clin Invest (1995) 1.99
Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res (1996) 1.95
IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes (2001) 1.92
Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res (1990) 1.89
Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res (1990) 1.85
Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ Res (2001) 1.83
Exercise hyperventilation chronic congestive heart failure, and its relation to functional capacity and hemodynamics. Am J Cardiol (1992) 1.78
Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest (1998) 1.73
Dilated and failing cardiomyopathy in bradykinin B(2) receptor knockout mice. Circulation (1999) 1.73
Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans. J Am Coll Cardiol (1994) 1.69
The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol (1995) 1.64
Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res (1991) 1.63
Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ Res (1986) 1.63
Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int (2001) 1.58
The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation (1995) 1.56
Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart. Circ Res (1999) 1.56
Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J (2000) 1.54
Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes (2001) 1.53
Occurrence of oxidative stress during reperfusion of the human heart. Circulation (1990) 1.53
Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent. Lab Invest (2000) 1.51
Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol (1996) 1.49
Insulin-like growth factor-1 and myocyte growth: the danger of a dogma. Part I. Postnatal myocardial development: normal growth. Cardiovasc Res (1996) 1.49
Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. II. Tissue composition, capillary growth, and sarcoplasmic alterations. Circ Res (1980) 1.47
Differences in load dependence of relaxation between the left and right ventricular myocardium as a function of age in rats. Circ Res (1989) 1.47
PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol (1992) 1.43
Insulin-like growth factor-1 and myocyte growth: the danger of a dogma part II. Induced myocardial growth: pathologic hypertrophy. Cardiovasc Res (1996) 1.41
Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol (1992) 1.41
Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. I. Hypertrophy, hyperplasia, and binucleation of myocytes. Circ Res (1980) 1.40
Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol (1997) 1.39
Absolute morphometric study of myocardial hypertrophy in experimental hypertension. II. Ultrastructure of myocytes and interstitium. Lab Invest (1978) 1.33
Myocyte cell loss and myocyte hypertrophy in the aging rat heart. J Am Coll Cardiol (1986) 1.33
Role of stem cells in cardiovascular biology. J Thromb Haemost (2011) 1.31
Parapharyngeal space lesions syncope-syndrome. A newly proposed reflexogenic cardiovascular syndrome. Eur Heart J (1993) 1.30
Morphometry of the renal corpuscle during postnatal growth and compensatory hypertrophy. Kidney Int (1980) 1.29
Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review. J Am Coll Cardiol (1986) 1.29
End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res (1994) 1.22
Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol (1994) 1.21
Morphometric analysis of biologic processes. Lab Invest (1984) 1.21
Telomere shortening is an in vivo marker of myocyte replication and aging. Am J Pathol (2000) 1.21
Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defences against oxygen toxicity. J Mol Cell Cardiol (1985) 1.20
Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure. Circ Res (2001) 1.19
Stereological measurement of cellular and subcellular hypertrophy and hyperplasia in the papillary muscle of adult rat. J Mol Cell Cardiol (1980) 1.18
Morphometry of exercise-induced right ventricular hypertrophy in the rat. Circ Res (1983) 1.18
Morphometry of the renal corpuscle during normal postnatal growth and compensatory hypertrophy. A light microscope study. J Cell Biol (1977) 1.18
Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ Res (1994) 1.17
Severe myocardial dysfunction induced by ventricular remodeling in aging rat hearts. Am J Physiol (1990) 1.13
Angiotensin II activates programmed myocyte cell death in vitro. Exp Cell Res (1997) 1.11
The effects of ruthenium red on mitochondrial function during post-ischaemic reperfusion. J Mol Cell Cardiol (1982) 1.11
Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart. Proc Natl Acad Sci U S A (2001) 1.10
Myocyte cell death and ventricular remodeling. Curr Opin Nephrol Hypertens (1997) 1.10
Morphometric study of early postnatal development of the thoracic aorta in the rat. Circ Res (1980) 1.10
Left ventricular hypertrophy: a cytometric study on 42 human hearts. J Mol Cell Cardiol (1977) 1.10
Ischaemic myocardial injury and ventricular remodelling. Cardiovasc Res (1993) 1.08
Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice. Circ Res (1999) 1.08
Cellular basis of ventricular remodeling after myocardial infarction. Am J Cardiol (1991) 1.07
Myocyte cell death in the diseased heart. Circ Res (1998) 1.07